ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2385

Reasons for Non-Vaccination in Rheumatoid Arthritis and Spondyloarthritis Patients

Charlotte Hua1, Jacques Morel2, Bernard Combe1 and Cédric Lukas1,3, 1Immuno-Rhumatologie, Hôpital Lapeyronie, Montpellier, France, 2Department of Rheumatology, Hôpital Lapeyronie, Montpellier, France, 3Immuno-Rhumatologie, Hopital Lapeyronie, Montpellier, France

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Rheumatoid arthritis (RA), spondylarthropathy and vaccines

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects (ACR): Impact of Various Interventions and Therapeutic Approaches

Session Type: Abstract Submissions (ACR)

Background/Purpose: Patients with inflammatory rheumatic diseases are at increased risk of infections when compared to healthy controls. Despite the fact that part of these infections could easily be prevented by available vaccines, vaccination coverage remains very low in France. The aim of this study was to evaluate the reasons why rheumatoid arthritis (RA) and spondyloarthritis (Sp) patients had not been vaccinated against influenza and streptococcus infections.

Methods: In this French observational multicenter study, questionnaires were completed by RA and Sp patients referred to rheumatology departments from December 2012 to November 2013. The questionnaires consisted of questions about pneumococcal or influenza vaccinations, about the prescribing physician and, if applicable, about the reasons of non-vaccination. Clinical and demographic data were also collected.

Results: 268 RA patients and 189 Sp patients from 4 centers were included. Vaccination coverage was respectively 53% and 54.5% for pneumococcal vaccine and 59.7% and 47.1% for influenza vaccine. Lack of proposal was the main reason for non vaccination for pneumococcal (78.2% for RA and 78.9% for Sp patients- Figure 1) and influenza vaccine (48.1% and 61.1%- Figure 2). For pneumococcal vaccine, predictive factors for proposal were: history of RTX treatment (p= 0,0001) for RA patients and treatment with anti-TNFα (p=0.006) for Sp patients. For influenza vaccine, predictive factors for proposal were: increased age (p= 0.01) and current biologic treatment (p=0.002) in RA patients and presence of co-morbidities (p=0.004) in Sp patients.

Conclusion: Despite the recognized usefulness of vaccination among patients with inflammatory rheumatic diseases and the current international recommendations, we found that the vaccination coverage of patients from 4 French centers is low, mainly due to the lack of vaccine proposal by the practitioners. These findings are consistent with data from other countries and highlight the need of pursuing information of the patients and their doctors.

 


Disclosure:

C. Hua,
None;

J. Morel,
None;

B. Combe,
None;

C. Lukas,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reasons-for-non-vaccination-in-rheumatoid-arthritis-and-spondyloarthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology